Back

Improvement in left ventricular ejection fraction with quadruple therapy in patients with heart failure with reduced ejection fraction

17 May 2025 (15:51 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - heart failure with HFrEF (1) Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Richard Odai

Swansea (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Does gender really affect the prognosis of heart failure patients with reduced ejection fraction?
Doctor O. Hattab (Oujda, MA)
Abstract Slides Video
Presentation thumbnail
Predict-CCM: an italian multicenter study to assess the predictive value of dobutamine echo-stress in the clinical response to cardiac contractility modulation therapy (CCM)
Miss A. Roccabruna (Rovigo, IT)
Abstract Slides Video
Presentation thumbnail
Impact of education on quality of life patients with heart failure with reduced ejection fraction
Professor L. Dizdarevic-Hudic (Tuzla, BA)
Abstract Slides Video
Presentation thumbnail
Delphi study of management of patient with HFrEF in Spain: post-discharge follow-up of a patient with an episode of WHF
Doctor J. Morgado (Seville, ES)
Abstract Slides Video
Presentation thumbnail
The effect of carboxymaltose on proBNP levels in patients with chronic heart failure and reduced left ventricular ejection fraction
Professor G. Igimbayeva (Karaganda, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - heart failure with HFrEF (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 15:51 CET
You may be interested in
thumbnail
Congress Presentation
Optimizing heart failure management: impact of quadruple therapy initiation at discharge following decompensation events in patients with reduced ejection fraction
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?
thumbnail
Congress Session
Insights from recent HFrEF trials 2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources